Services

Histology

Pharmacology

Medical Device Testing

In Vitro Screening

Animal Model Development

Custom Assay Development

Vivarium Rental

Toxicology

Species

Non-human Primates

Dogs

Mini-pigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Career

Request a Quote

Logo
☰
  • Services ⌄
    • Histology
    • Pharmacology
    • Medical Device Testing
    • In Vitro Screening
    • Animal Model Development
    • Custom Assay Development
    • Vivarium Rental
    • Toxicology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Mini-pigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Career
    • Request a Quote

Gottlieb Provides Update One Year after the Cures Act

  • Post author:Sam
  • Post published:November 30, 2017
  • Post category:Drug Industry Daily

As research advances into the biological underpinnings of diseases such as cancer, the FDA is expecting to see more drugs providing more data demonstrating survival benefit earlier in product development,…

Continue ReadingGottlieb Provides Update One Year after the Cures Act

Mettler-Toledo to Begin Layoffs in March, 69 Employees Affected

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Mettler-Toledo will begin to issue pink slips in March to employees at an upstate New York manufacturing facility. Source: BioSpace

Continue ReadingMettler-Toledo to Begin Layoffs in March, 69 Employees Affected

Mind-Blowing: Amgen's Aimovig Halves Length of Migraine Attacks in Phase III Study

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Migraine sufferers may find some new relief as Amgen unveiled results from a late-stage study that shows its Phase III drug Aimovig reduced monthly migraine attacks in half. Source: BioSpace

Continue ReadingMind-Blowing: Amgen's Aimovig Halves Length of Migraine Attacks in Phase III Study

Bayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

The company's head of Development, Joerg Moeller, is taking the reins of the company's new R&D program. Source: BioSpace

Continue ReadingBayer Head of Discovery Exits as Drugmaker Combines Pharma R&D Unit

3 Big Pharmas That Could be Winners for Investors in the Long Run

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace

Continue Reading3 Big Pharmas That Could be Winners for Investors in the Long Run

Cambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

The round was co-led by Eight Roads Ventures and Cowen Healthcare Investments. Source: BioSpace

Continue ReadingCambridge's Semma Therapeutics Lands $114M for Novel Diabetes Quest

Genmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Genmab just received a $20M milestone payment from Janssen Biotech. Source: BioSpace

Continue ReadingGenmab and Johnson & Johnson Rake in the Bucks Together, Sparking Takeover Speculation

Sanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

Sanofi's setback could open the door for rival drugmaker Takeda. Source: BioSpace

Continue ReadingSanofi Takes a $120M Hit as Potential Dengue Vaccine Blockbuster Dealt Safety Blow

Boston's Anti-Aging Startup resTORbio Scores $40M

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

This financing brings the total capital raised this year to $65 million, including a $25 million Series A financing that was completed earlier this year. Source: BioSpace

Continue ReadingBoston's Anti-Aging Startup resTORbio Scores $40M

Sexual Harassment Scandals Hit Novartis and Pfizer's Korea Units

  • Post author:Sam
  • Post published:November 29, 2017
  • Post category:BioPharma

On Wednesday, KBR reported that a male employee at Novartis Korea reported to the company that his female boss sexually harassed him in September. Source: BioSpace

Continue ReadingSexual Harassment Scandals Hit Novartis and Pfizer's Korea Units
  • Go to the previous page
  • 1
  • …
  • 242
  • 243
  • 244
  • 245
  • 246
  • 247
  • 248
  • …
  • 610
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:

6042 Cornerstone Court W

Suite E

San Diego, CA 92121

Social:
© 2025 BioLegacy Research. All rights reserved.